HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration.

AuthorsBashar Al Dweik, Rabah Redjoul, Sylvie Bastuji-Garin, Florence Beckerich, Christine Robin, Cécile Pautas, Andréa Toma, Ludovic Cabanne, Sébastien Maury, Catherine Cordonnier
JournalAmerican journal of hematology (Am J Hematol) Vol. 91 Issue 4 Pg. E276-8 (Jun 2016) ISSN: 1096-8652 [Electronic] United States
PMID26799506 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antilymphocyte Serum
  • Immunosuppressive Agents
Topics
  • Antilymphocyte Serum (administration & dosage, adverse effects)
  • Humans
  • Immunosuppressive Agents (administration & dosage, adverse effects)
  • Incidence
  • Lymphopenia (epidemiology, etiology)
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: